ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
State Bank of India (PK)

State Bank of India (PK) (SBKFF)

91.35
0.00
(0.00%)
Closed January 04 4:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
91.35
Bid
82.93
Ask
102.57
Volume
98
0.00 Day's Range 0.00
74.9918 52 Week Range 112.85
Market Cap
Previous Close
91.35
Open
-
Last Trade
28
@
92.545
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
668
Shares Outstanding
8,924,611,707
Dividend Yield
2.90%
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
3.27T
Net Profit
670.85B

About State Bank of India (PK)

Sector
Commercial Banks, Nec
Industry
Commercial Banks, Nec
Website
Headquarters
Mumbai, Maharashtra, Ind
Founded
-
State Bank of India (PK) is listed in the Commercial Banks sector of the OTCMarkets with ticker SBKFF. The last closing price for State Bank of India (PK) was $91.35. Over the last year, State Bank of India (PK) shares have traded in a share price range of $ 74.9918 to $ 112.85.

State Bank of India (PK) currently has 8,924,611,707 shares outstanding. The market capitalization of State Bank of India (PK) is $815.26 billion.

SBKFF Latest News

Ex-Dividend

Fri, May 24, 2013 08:00 - State Bank of India (SBKFF: OTC Link) - Ex-Dividend - As of Tue, May 28, 2013, State Bank of India traded ex-dividend. State Bank of India will disburse a Cash Dividend...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10091.3591.3591.3520691.35CS
4-9.51-9.42891136228100.86100.8691.35132999.77369609CS
12-5.15-5.3367875647796.510191.3566899.499786CS
26-10.0634-9.92314625089101.4134112.8591.3570499.39699281CS
5216.358221.813318256174.9918112.8574.991858698.76372213CS
15627.943.971631205763.45112.8562.7565785.02427281CS
26045.498.8030467945.95112.8519.934125854.06171652CS

SBKFF - Frequently Asked Questions (FAQ)

What is the current State Bank of India (PK) share price?
The current share price of State Bank of India (PK) is $ 91.35
How many State Bank of India (PK) shares are in issue?
State Bank of India (PK) has 8,924,611,707 shares in issue
What is the market cap of State Bank of India (PK)?
The market capitalisation of State Bank of India (PK) is USD 815.26B
What is the 1 year trading range for State Bank of India (PK) share price?
State Bank of India (PK) has traded in the range of $ 74.9918 to $ 112.85 during the past year
What is the reporting currency for State Bank of India (PK)?
State Bank of India (PK) reports financial results in INR
What is the latest annual turnover for State Bank of India (PK)?
The latest annual turnover of State Bank of India (PK) is INR 3.27T
What is the latest annual profit for State Bank of India (PK)?
The latest annual profit of State Bank of India (PK) is INR 670.85B
What is the registered address of State Bank of India (PK)?
The registered address for State Bank of India (PK) is CORPORATE CENTRE, 14TH FLOOR, STATE BANK BHAVAN, MADAME CAMA ROAD, MUMBAI, MAHARASHTRA, 400021
What is the State Bank of India (PK) website address?
The website address for State Bank of India (PK) is www.sbi.co.in
Which industry sector does State Bank of India (PK) operate in?
State Bank of India (PK) operates in the COMMERCIAL BANKS, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EGIOQEdgio Inc (CE)
$ 0.01
(999,900.00%)
584
AAGRAfrican Agriculture Holdings Inc (CE)
$ 0.008
(799,900.00%)
477
THCBFTHC Biomed International Limited (CE)
$ 0.001
(99,900.00%)
100
AEORFAEON REIT Investment Corporation (PK)
$ 796.08
(26,436.00%)
1
EFTReFFECTOR Therapeutics Inc (CE)
$ 0.0002
(19,900.00%)
225
UFABQUnique Fabricating Inc (CE)
$ 0.000001
(-99.98%)
102.53k
VICFFVice Health and Wellness Inc (CE)
$ 0.000001
(-99.97%)
996
SAFSSafer Shot Inc (CE)
$ 0.000001
(-99.93%)
2.54M
ERFBERF Wireless Inc (CE)
$ 0.0001
(-99.89%)
99.77k
ARVLFArrival (CE)
$ 0.0002
(-99.60%)
42.86k
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.0038
(52.00%)
608.97M
HMBLHUMBL Inc (PK)
$ 0.0009
(0.00%)
546.25M
PHILPHI Group Inc (PK)
$ 0.0003
(0.00%)
501.07M
CBIACanopus Biopharma Inc (PK)
$ 0.0002
(100.00%)
281.95M
RDARRaadr Inc (PK)
$ 0.00125
(-10.71%)
169.44M

Discussion

View Full Feed
elks elks 6 minutes ago
Wtf.
TWOH
fuagf fuagf 7 minutes ago
Security risk? Shrug. Trump flips on Tik Tok, because it's good for him.

PatriotTakes 🇺🇸
@patriottakes
Nikki Haley comes out against Trump’s plan to save TikTok, but won’t mention him by name

https://pbs.twimg.com/media/GgeV_fjXkAAgNe7?form
XMaster2023 XMaster2023 9 minutes ago
Roman, there could already be deals cut and the only thing we are waiting for now is approval. I actually believe this is the case and NWBO is under a gag order as BP would not want anything getting out until approval.
NWBO
JJ8 JJ8 11 minutes ago
I am encouraged of what I see of the Histogram in the Weekly Chart showing that a new uptrend appears to be in the process of developing for the AMD share price.

Hopefully that is going to continue... and lead to a share price breakout soon.

We shall see.
AMD
boi568 boi568 12 minutes ago
Anavex has delayed PD in order to wait out the development of a reliable biomarker, which has happened only during the past few months. They may also have understandably diverted some resources towards a successful MAA.
AVXL
boi568 boi568 14 minutes ago
There is no regulatory "sufficiency" test, other than being better than the standard of care, if one exists. The article makes the case that blarcamesine is better than any approved AD drug. The FDA employs a risk/benefit analysis, and you want your drug candidate to more than offset any risks with
AVXL
benz280c benz280c 14 minutes ago
Changing the innards of a Chevy with Ferrari parts is a game changer. Learn about the Z06. Maybe you will appreciate what is set to occur when the cusip, name, and ticker changes in this instance. Ignorance is alive and well by folks old enough to know better. Sad!
https://www.detroitnews.com
GDVM
flipper44 flipper44 15 minutes ago
Do you happen to have a link to that example you gave?
NWBO
ty3 ty3 17 minutes ago
Is that the company claiming to make water from air lol ? I think I posted a lol awhile back.
CGAC
OMOLIVES OMOLIVES 19 minutes ago
Sorry to go off tilt..it's your fault. last one........killer:

https://www.youtube.com/watch?v=wwIJk0C0xY0
DiamondHealer95 DiamondHealer95 20 minutes ago
I remember a time when dimes and mojo were wildly praised for their claim that this stock would hit $1-$3 by June. Just like Robert Sullivan on their Facebook page.

It didn't.

Stop considering their posts. They know next to nothing.

By the way mojo - yo
KBLB
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 20 minutes ago
which position will the EMA take? (conventional), or will they go outside the box and follow in the steps of the authors, making the MABs relevant to the decision. The EMA has hinted that they are not happy with the MABs. The question might be, will the EMA approve a drug that can show partial pos
AVXL
BDEZ BDEZ 21 minutes ago
A thug not even born here...smh.
Huggy Bear Huggy Bear 21 minutes ago
Actually that's Smokey Robinson, of the baby boomer generation, but what's an education worth nowadays?
HMBL
3331 3331 21 minutes ago
OTC is entering a golden age in 2025 - Chartmaster.

With news, BIEL could lead the way!
BIEL
skitahoe skitahoe 22 minutes ago
While I know nothing about the specific trial, as I see it if the regulators accept the protocol of a specific trial they're also accepting the fact that if results warrant, they'll approve the drugs in the trial. It's up to the company to establish the acceptance criteria, which the regulator acce
NWBO
boi568 boi568 22 minutes ago
The regulatory authorities don't care who is speaking at a conference, they just care what is submitted as part of a drug application.

BTW, I happen to think personal testimony is a gimmick that will not impress cynical executives.
AVXL
Acme Investments Acme Investments 27 minutes ago
People just don't understand how the Otc works!! If they say it runs it runs!! Doesn't matter if you like the fundamentals!!
AITX
DiamondHealer95 DiamondHealer95 27 minutes ago
There it is! The MONDAY COULD BE EXCITING for the 457th time in 13 months!

85%+ Monday PR releases and this user is betting on an update at anytime (no shit) and is picking... MONDAY!

That folks is what we call a sure bet and staying the obvious.

That bei
KBLB
SSKILLZ1 SSKILLZ1 27 minutes ago
Pick 4 Contest #21 Contest Info. In.

Hope everyone enjoys. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-21-46064
SSKILLZ1 SSKILLZ1 27 minutes ago
Pick 4 Contest #21 Contest Info. In.

Hope everyone enjoys. Hope this helps.

https://investorshub.advfn.com/Pick-4-Contest-No-21-46064
Bob1968 Bob1968 27 minutes ago
Interview with Intel CEO

https://www.youtube.com/watch?v=DpJqRHFYUqk
INTC
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 28 minutes ago
I just bought a beautiful sporty looking SUV and it cost me almost 50K come on avxl I'm counting on you I got to get that money back LOL

Same here with the red 'Stang. Let's make some cash!
AVXL
mrfence mrfence 29 minutes ago
Don't let the paid shills fluster yah. Just know when they come at yah it's because you're speaking valid truth. That threatens their failing ruse. Oh, and thanks to JPS lawyers for making the case for commons while trying to rob them a second time :-D

Your Recent History

Delayed Upgrade Clock